448 related articles for article (PubMed ID: 18081555)
1. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice.
Valle A; Hoggard N; Adams AC; Roca P; Speakman JR
J Neuroendocrinol; 2008 Jan; 20(1):79-84. PubMed ID: 18081555
[TBL] [Abstract][Full Text] [Related]
2. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
Larsen PJ; Vrang N; Petersen PC; Kristensen P
Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse.
Calapai G; Corica F; Allegra A; Corsonello A; Sautebin L; De Gregorio T; Di Rosa M; Costantino G; Buemi M; Caputi AP
Br J Pharmacol; 1998 Oct; 125(4):798-802. PubMed ID: 9831917
[TBL] [Abstract][Full Text] [Related]
4. Effect of neuromedin S on feeding regulation in the Japanese quail.
Shousha S; Nakahara K; Sato M; Mori K; Miyazato M; Kangawa K; Murakami N
Neurosci Lett; 2006 Jan; 391(3):87-90. PubMed ID: 16159696
[TBL] [Abstract][Full Text] [Related]
5. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
6. Central apelin-13 inhibits food intake via the CRF receptor in mice.
Lv SY; Yang YJ; Qin YJ; Mo JR; Wang NB; Wang YJ; Chen Q
Peptides; 2012 Jan; 33(1):132-8. PubMed ID: 22108714
[TBL] [Abstract][Full Text] [Related]
7. Acute injection of ASP in the third ventricle inhibits food intake and locomotor activity in rats.
Roy C; Roy MC; Gauvreau D; Poulin AM; Tom FQ; Timofeeva E; Richard D; Cianflone K
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E232-41. PubMed ID: 21540449
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
9. Feeding and behavioural effects of central administration of the melanocortin 3/4-R antagonist SHU9119 in obese and lean Siberian hamsters.
Schuhler S; Horan TL; Hastings MH; Mercer JG; Morgan PJ; Ebling FJ
Behav Brain Res; 2004 Jul; 152(2):177-85. PubMed ID: 15196785
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the Japanese quail.
Shousha S; Nakahara K; Nasu T; Sakamoto T; Murakami N
Neurosci Lett; 2007 Mar; 415(2):102-7. PubMed ID: 17267112
[TBL] [Abstract][Full Text] [Related]
11. Nesfatin-1 exerts long-term effect on food intake and body temperature.
Könczöl K; Pintér O; Ferenczi S; Varga J; Kovács K; Palkovits M; Zelena D; Tóth ZE
Int J Obes (Lond); 2012 Dec; 36(12):1514-21. PubMed ID: 22290539
[TBL] [Abstract][Full Text] [Related]
12. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
13. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.
Kim ER; Leckstrom A; Mizuno TM
Behav Brain Res; 2008 Dec; 194(1):66-71. PubMed ID: 18639588
[TBL] [Abstract][Full Text] [Related]
14. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.
Egecioglu E; Ploj K; Xu X; Bjursell M; Salomé N; Andersson N; Ohlsson C; Taube M; Hansson C; Bohlooly-Y M; Morgan DG; Dickson SL
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E708-16. PubMed ID: 19584200
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular administration of apelin-13 inhibits distal colonic transit in mice.
Yang YJ; Lv SY; Xiu MH; Xu N; Chen Q
Peptides; 2010 Dec; 31(12):2241-6. PubMed ID: 20849897
[TBL] [Abstract][Full Text] [Related]
16. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
17. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters.
Snodgrass-Belt P; Gilbert JL; Davis FC
Brain Res; 2005 Mar; 1038(2):171-82. PubMed ID: 15757633
[TBL] [Abstract][Full Text] [Related]
18. Central effects of neuromedin U in the regulation of energy homeostasis.
Nakazato M; Hanada R; Murakami N; Date Y; Mondal MS; Kojima M; Yoshimatsu H; Kangawa K; Matsukura S
Biochem Biophys Res Commun; 2000 Oct; 277(1):191-4. PubMed ID: 11027662
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
20. The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse.
Weiland TJ; Voudouris NJ; Kent S
Physiol Behav; 2004 Sep; 82(2-3):471-6. PubMed ID: 15276812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
